Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caribou Biosciences (CRBU) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for Caribou Biosciences (CRBU) over the last 6 years, with Dec 2024 value amounting to -$149.1 million.

  • Caribou Biosciences' Consolidated Net Income rose 23.11% to -$29.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$158.8 million, marking a year-over-year increase of 3.88%. This contributed to the annual value of -$149.1 million for FY2024, which is 46.08% down from last year.
  • Caribou Biosciences' Consolidated Net Income amounted to -$149.1 million in FY2024, which was down 46.08% from -$102.1 million recorded in FY2023.
  • Caribou Biosciences' Consolidated Net Income's 5-year high stood at -$34.3 million during FY2020, with a 5-year trough of -$149.1 million in FY2024.
  • Over the past 3 years, Caribou Biosciences' median Consolidated Net Income value was -$102.1 million (recorded in 2023), while the average stood at -$116.9 million.
  • Data for Caribou Biosciences' Consolidated Net Income shows a maximum YoY tumbled of 95.07% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Caribou Biosciences' Consolidated Net Income stood at -$34.3 million in 2020, then crashed by 95.07% to -$66.9 million in 2021, then crashed by 48.56% to -$99.4 million in 2022, then declined by 2.66% to -$102.1 million in 2023, then crashed by 46.08% to -$149.1 million in 2024.